TRIal For Efficacy of Capre on hyperTriglyceridemiA
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 387 participants.
Also called NCT01455844
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 387 participants
- Sponsor
- Registry
-
NCT01455844
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT01455844. Randomized; double masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2014-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TRIal For Efficacy of Capre on hyperTriglyceridemiA
- Acronym
- TRIFECTA
- Condition
- Hypertriglyceridemia
- Intervention (Drug)
- CaPre (TM)
- Intervention (Other)
- Placebo
- Intervention (Drug)
- CaPre (TM)
- Lead sponsor
- Grace Therapeutics Inc.
- Collaborator
- JSS Medical Research Inc.
Record details
- Record id
cardio:ct-nct01455844- Content hash
b28c1888bc9d5d28639800211b42a3973d77f0d59d2e55fb2e28ffa5e3ca2fa2